Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-06

Clinical Trial Update: Profiling the Skin Microbiome in Response to Altreno in Acne Patients [Phase 4]

View source ↗

Summary

Phase 4 trial updating profiling of the skin microbiome in acne patients treated with Altreno; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALTRENO (TRETINOIN)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Acne, Healthy | Phase 4 | Status: COMPLETED | Results posted: 2024-02-06